This post was originally published on Medscape
You will shortly be re-directed to the publisher's website
Children with myopia receiving 0.05% atropine showed less progression of the eye condition and axial elongation than those receiving placebo, according to 3-year results of the MOSAIC trial.
Medscape Medical News